| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 苦鬼臼毒素; Picropodophyllotoxin | CFN90443 | 17434-18-3 | C22H22O8 = 414.4 | 20mg | QQ客服：1413575084 |
| (-)-丁香树脂醇二葡萄糖甙; 丁香树脂醇双葡萄糖苷; Syringaresinol-di-O-glucoside | CFN90458 | 66791-77-3 | C34H46O18 = 742.71 | 20mg | QQ客服：215959384 |
| 橄榄树脂素9-乙酸酯; Olivil monoacetate | CFN97860 | 1016974-78-9 | C22H26O8 = 418.44 | 5mg | QQ客服：3257982914 |
| 4'-去甲鬼臼毒素; 4'-Demethylpodophyllotoxin | CFN90483 | 40505-27-9 | C21H20O8 = 400.37 | 20mg | QQ客服：3257982914 |
| 裂榄脂素; Bursehernin | CFN92058 | 40456-51-7 | C21H22O6 = 370.4 | 5mg | QQ客服：1413575084 |
| Pluviatolide; Pluviatolide | CFN92059 | 28115-68-6 | C20H20O6 = 356.4 | 5mg | QQ客服：3257982914 |
| 丁香树脂酚; Syringaresinol | CFN92060 | 487-35-4 | C22H26O8 = 418.4 | 10mg | QQ客服：215959384 |
| 叶下珠新素; Phyltetralin | CFN92069 | 123048-17-9 | C24H32O6 = 416.5 | 5mg | QQ客服：2159513211 |
| Isolintetralin; Isolintetralin | CFN92070 | 145459-30-9 | C23H28O6 = 400.5 | 5mg | QQ客服：215959384 |
| 6-O-苯甲酰戈米辛O; 6-O-benzoylgomisin O | CFN92113 | 130783-32-3 | C30H32O8 = 520.6 | 10mg | QQ客服：1413575084 |
| 内南五味子酯 A; Interiotherin A | CFN92114 | 181701-06-4 | C29H28O8 = 504.5 | 5mg | QQ客服：215959384 |
| (-)-Haplomyrfolin; (-)-Haplomyrfolin | CFN92253 | 85404-48-4 | C20H20O6 = 356.4 | 5mg | QQ客服：1457312923 |
| Kusunokinin; Kusunokinin | CFN92254 | 58311-20-9 | C21H22O6 = 370.4 | 5mg | QQ客服：2056216494 |
| (-)-扁柏脂素，荜澄茄内脂; (-)-Hinokinin | CFN92255 | 26543-89-5 | C20H18O6 = 354.4 | 5mg | QQ客服：2056216494 |
| Rubrisandrin A; Rubrisandrin A | CFN92278 | 919289-30-8 | C22H28O6 = 388.5 | 5mg | QQ客服：2056216494 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)